학술논문
P1.01-78 Treatment-Related Adverse Events in Patients with Advanced NSCLC Treated with First-Line Atezolizumab Chemoimmunotherapy
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S390-S390
Subject
Language
ISSN
1556-0864